GDF8 inhibits bone formation and promotes bone resorption in mice

Area of Science:

• Bone Biology
• Endocrinology
• Skeletal Muscle Physiology

Background:

• Growth Differentiation Factor 8 (GDF8), also known as myostatin, is a key regulator of skeletal muscle mass.
• GDF8 belongs to the transforming growth factor (TGF)-β superfamily.
• While GDF8's role in muscle is established, its function in bone metabolism remains largely undefined.

Purpose of the Study:

• To elucidate the specific roles of GDF8 in both bone formation and resorption.
• To investigate the therapeutic potential of targeting GDF8 for bone-related disorders.

Main Methods:

• In vitro studies using primary mouse osteoblasts and RANKL-induced osteoclastogenesis.
• In vivo experiments involving intraperitoneal injection of recombinant GDF8 in mice.
• Administration of a GDF8 neutralizing antibody to aged mice.

Main Results:

• GDF8 demonstrated a negative regulatory effect on osteoblast activity in vitro.
• GDF8 promoted osteoclastogenesis in vitro, indicating a role in bone resorption.
• In vivo, GDF8 administration led to decreased bone formation and increased bone resorption.
• GDF8 antibody treatment in aged mice successfully stimulated new bone formation and inhibited resorption.

Conclusions:

• GDF8 significantly regulates both bone formation and resorption processes.
• Targeting GDF8, for example, with neutralizing antibodies, presents a promising therapeutic strategy for osteoporosis.
• Further research into GDF8 modulation could offer novel treatments for bone metabolic diseases.